webinar register page

Webinar banner
Pulmonary Arterial Hypertension: A Roadmap for ACHD Patients #ACHACares
Have you been told you have pulmonary vascular disease/pulmonary arterial hypertension (PAH)? Do you know that it can develop due to certain types of congenital heart disease (CHD)? Do you know how that happens? Do you know the different types of treatment? If you want to learn more, you will want to attend this webinar. Dr Ian Harris, ACHD cardiologist, will review what causes PAH and discuss the types of clinical research going on in the area of therapy for PAH. He will also go over current treatments and a general approach to using these therapies.

Sponsorship support provided by Actelion Pharmaceuticals US, Inc.

Jul 22, 2020 07:00 PM in Eastern Time (US and Canada)

* Required information


Ian Harris, MD
Director of the Adult Congenital Cardiology Program @University of California San Francisco
Dr. Ian Harris earned his medical degree from UCSF School of Medicine and completed his residency in internal medicine at Barnes-Jewish Hospital. Dr. Harris returned to UCSF Medical Center to complete his cardiology and adult congenital cardiology fellowships, as well as a research fellowship in developmental biology at the UCSF Cardiovascular Research Institute. Dr. Harris is the Director of the Adult Congenital Cardiology Program at UCSF. He is board certified in ACHD, internal medicine and cardiovascular disease and is also a member of the ACHA Medical Advisory Board.